Market Size
The Cold Plasma in Healthcare Market was growing at a CAGR of 15.4% during the forecast period (2026–2033).
Plasma can be defined as partially ionized gas which contains an approximately equal number of positive and negative particles. Plasmas can be classified into hot plasmas (also defined as near-equilibrium plasmas) and cold plasmas (nonequilibrium plasmas). In cold plasmas, the electron temperature is relatively high (1–10 eV) while the translational energy of heavy particles remains very low, with temperature close to room one, and the ionization degree is typically low. The electric field is applied to a gas; energy is transferred more efficiently to the free electrons naturally present in the gas than to the ions. The accelerated electrons then transfer the energy to heavier particles.
In Biomedicine, cold plasma is used to treat teeth, skin, and sterilize medical devices. In the food industry, cold plasma is used in the packaging process and food production.
Cold Plasma In Healthcare Market Scope
| Metrics | Details |
| Market CAGR | 15.4% |
| Segments Covered | By Pet Type, By Ingredient, By Form, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Market Dynamics
The Cold Plasma In Healthcare Market is expected to grow due to the benefits of cold plasma techniques and their use in wound healing. The cold plasma in the field of medicine is thus blooming quickly as cold plasma has the ability to kill bacteria and prevent infections.
Benefits of cold plasma technology
Cold plasma technology has diverse applications in several industries. Cold plasma is a novel non-thermal technology that uses energetic, reactive gases to inactivate contaminating microbes on meats, fruits, poultry and vegetables. The ability of cold atmospheric plasma to inactivate bacteria recently gained more relevance because modern society has been facing several serious healthcare challenges.
Cold plasma in infection prevention
Cold plasma has demonstrated broad bactericidal activity regardless of the bacterial species and resistance in vitro and in vivo. The development of cold plasma now allows Application to viable tissue. The efficacy of a cold plasma device in reducing bacterial carriage and pain in a patient with chronic nasopharyngeal and external auditory canal infection after cholesteatoma surgery is reported.
Street traffic wounds are the main source of death among individuals mature somewhere in the range of 15 and 29 years. Consistently the existence of more than 1.35 million individuals are sliced short because of the streetcar accident. In this manner, since there are countless injury and wound administration cases noticed yearly, the appropriation pace of cold plasma is required to be high for twisted recuperating across the medical clinics and medical services offices.
High investment and limited commercialization
There is a high investment required for cold plasma technology as the equipment used in this is very costly and requires special operating conditions. As a result, cold plasma has witnessed limited commercialization. The successful applications of cold plasma have been limited to a few sectors. The less awareness of cold plasma has also inhibited the greater adoption of this technology.
Segment Analysis
On the basis of application, the cold plasma in the healthcare market is divided into wound healing, blood coagulation, dentistry, cancer treatment and other medical applications.
Cold plasma is an innovative approach to wound healing. In vitro and initial clinical studies for chronic wounds in animals and humans have shown that CAP decreases their bacterial load and promotes healing without significant side effects on normal tissue. Additionally, CAP was found to facilitate the transformation of the chronic wound from becoming a stagnating wound or an acute healing wound through modulation of the inflammation stimulation of different growth factors and tissue reactive species interaction.
Of these, 16.2 million population are above 67 years of age, and it is projected to reach 21.4 million by 2040. With the increase in the geriatric population, there is an increasing number of diabetic populations, resulting in chronic wounds such as foot ulcers and thus boosting the overall market.
Based on regime, the Cold Plasma In Healthcare Market into low-pressure plasma and atmospheric cold plasma.
The low-pressure plasma is to witness growth in the forecast period.
The low-pressure cold plasma is estimated to hold the largest share in the market and is also expected to grow in the forecast period. A wide array of cold plasma systems operating at atmospheric pressure or in low-pressure treatment chambers are under development. Low-pressure plasmas are used for decontamination/sterilization in the food industry and medicine or the specific modification of the surface properties of materials.
Geographical Analysis
North America is expected to hold a significant share in the market and is expected to do the same in the forecast period.
North America has been found to dominate the market due to key companies investing in the market and the availability of various products. Furthermore, the growing prevalence of trauma cases and cancer patient pool is driving the growth of the market in North America.
On the other hand, the Asia-Pacific region is expected to see growth in the forecast period. With the rising demand for plasma therapies and rising production of polymers. Many global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
Competitive Landscape
The Cold Plasma In Healthcare Market is one of the most competitive markets. Some of the key companies in the global cold plasma market are U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited.
Recent Developments
In March 2026, Adtec Healthcare expanded its cold plasma medical devices for wound healing and infection control. The innovation focuses on antimicrobial effectiveness and faster recovery. This supports advanced clinical treatments.
In February 2026, Terraplasma GmbH (Viromed Group) introduced next-generation cold plasma systems for dermatology and chronic wound care. The development enhances treatment precision and safety. This benefits hospitals and clinics.
In January 2026, Nordson Corporation strengthened its plasma technology portfolio for medical applications. The focus is on sterilization and surface treatment. This supports improved healthcare hygiene standards.
